These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22101967)

  • 21. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
    Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
    Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.
    Ali B; Khan A; Alyami HS; Ullah M; Wahab A; Badshah M; Naz A
    PLoS One; 2021; 16(8):e0249075. PubMed ID: 34339440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of griseofulvin release from liquisolid compacts.
    Hentzschel CM; Alnaief M; Smirnova I; Sakmann A; Leopold CS
    Eur J Pharm Biopharm; 2012 Jan; 80(1):130-5. PubMed ID: 21846502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a liquisolid technique to cannabis sativa extract compacts: Effect of liquid vehicles on the dissolution enhancement and stability of cannabinoids.
    Jaipakdee N; Tabboon P; Limpongsa E
    Int J Pharm; 2022 Jan; 612():121277. PubMed ID: 34774694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
    Venkateswarlu K; Preethi JK; Chandrasekhar KB
    Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
    [No Abstract]   [Full Text] [Related]  

  • 28. Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms.
    Khames A
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1335-43. PubMed ID: 23706099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Oral Bioavailability of Etodolac by the Liquisolid Compact Technique: Optimisation, In-Vitro and In-Vivo Evaluation.
    Pathak BK; Raghav M; Thakkar AR; Vyas BA; Shah PJ
    Curr Drug Deliv; 2021; 18(4):471-486. PubMed ID: 33106143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.
    Thakkar HP; Vasava D; Patel AA; Dhande RD
    Ther Deliv; 2020 Feb; 11(2):83-96. PubMed ID: 31955698
    [No Abstract]   [Full Text] [Related]  

  • 31. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of physicochemical properties of piroxicam liquisolid compacts.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation concentration effect of propyleneglycol, glycerin, and polyethyleneglycol 400 to physical properties and dissolution rate of loratadine liquisolid tablet.
    Eryani MC; Hendradi E; Siswandono
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):583-587. PubMed ID: 34214337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique.
    Khames A
    Drug Deliv; 2017 Nov; 24(1):328-338. PubMed ID: 28165818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
    Karmarkar AB
    Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.
    Adibkia K; Shokri J; Barzegar-Jalali M; Solduzian M; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2014 Jan; 113():10-4. PubMed ID: 24060925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
    Szabados-Nacsa A; Sipos P; Martinek T; Mándity I; Blazsó G; Balogh Á; Szabó-Révész P; Aigner Z
    J Pharm Biomed Anal; 2011 May; 55(2):294-300. PubMed ID: 21316895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.